Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 214493
Company: ZYDUS
Company: ZYDUS
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
PIMAVANSERIN | PIMAVANSERIN TARTRATE | EQ 34MG BASE | CAPSULE;ORAL | Prescription | AB | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
01/16/2024 | ORIG-1 | Approval | STANDARD |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/214493Orig1s000ltr.pdf |
PIMAVANSERIN
CAPSULE;ORAL; EQ 34MG BASE
TE Code = AB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
NUPLAZID | PIMAVANSERIN TARTRATE | EQ 34MG BASE | CAPSULE;ORAL | Prescription | Yes | AB | 210793 | ACADIA PHARMS INC |
PIMAVANSERIN | PIMAVANSERIN TARTRATE | EQ 34MG BASE | CAPSULE;ORAL | Prescription | No | AB | 214493 | ZYDUS |